Back to top
more

Omnicell (OMCL)

(Delayed Data from NSDQ)

$28.43 USD

28.43
438,847

+0.64 (2.30%)

Updated Apr 23, 2024 04:00 PM ET

After-Market: $28.46 +0.03 (0.11%) 7:58 PM ET

Zacks Rank:

This is our short term rating system that serves as a timeliness indicator for stocks over the next 1 to 3 months. How good is it? See rankings and related performance below.

Zacks Rank Definition Annualized Return
1Strong Buy24.20%
2Buy18.04%
3Hold9.52%
4Sell5.20%
5Strong Sell2.60%
S&P50011.13%

Zacks Rank Education - Learn about the Zacks Rank

Zacks Rank Home - Zacks Rank resources in one place

Zacks Premium - The only way to fully access the Zacks Rank

3-Hold of 5     3    

Style Scores:

The Style Scores are a complementary set of indicators to use alongside the Zacks Rank. It allows the user to better focus on the stocks that are the best fit for his or her personal trading style.

The scores are based on the trading styles of Value, Growth, and Momentum. There's also a VGM Score ('V' for Value, 'G' for Growth and 'M' for Momentum), which combines the weighted average of the individual style scores into one score.

Value Score A
Growth Score A
Momentum Score A
VGM Score A

Within each Score, stocks are graded into five groups: A, B, C, D and F. As you might remember from your school days, an A, is better than a B; a B is better than a C; a C is better than a D; and a D is better than an F.

As an investor, you want to buy stocks with the highest probability of success. That means you want to buy stocks with a Zacks Rank #1 or #2, Strong Buy or Buy, which also has a Score of an A or a B in your personal trading style.

Zacks Style Scores Education - Learn more about the Zacks Style Scores

A Value B Growth F Momentum B VGM

Industry Rank:

The Zacks Industry Rank assigns a rating to each of the 265 X (Expanded) Industries based on their average Zacks Rank.

An industry with a larger percentage of Zacks Rank #1's and #2's will have a better average Zacks Rank than one with a larger percentage of Zacks Rank #4's and #5's.

The industry with the best average Zacks Rank would be considered the top industry (1 out of 265), which would place it in the top 1% of Zacks Ranked Industries. The industry with the worst average Zacks Rank (265 out of 265) would place in the bottom 1%.

Zacks Rank Education -- Learn more about the Zacks Rank
Zacks Industry Rank Education -- Learn more about the Zacks Industry Rank

Top 37% (94 out of 252)

Industry: Medical Info Systems

Zacks Premium FeatureView All Zacks #1 Ranked Stocks

Better trading starts here.

Balance Sheet

Research for OMCL

The Zacks Equity Research reports, or ZER for short, are our in-house, independently produced research reports.

The ever popular one-page Snapshot reports are generated for virtually every single Zacks Ranked stock. It's packed with all of the company's key stats and salient decision making information. Including the Zacks Rank, Zacks Industry Rank, Style Scores, the Price, Consensus & Surprise chart, graphical estimate analysis and how a stocks stacks up to its peers.

The detailed multi-page Analyst report does an even deeper dive on the company's vital statistics. In addition to all of the proprietary analysis in the Snapshot, the report also visually displays the four components of the Zacks Rank (Agreement, Magnitude, Upside and Surprise); provides a comprehensive overview of the company business drivers, complete with earnings and sales charts; a recap of their last earnings report; and a bulleted list of reasons to buy or sell the stock. It also includes an industry comparison table to see how your stock compares to its expanded industry, and the S&P 500.

Researching stocks has never been so easy or insightful as with the ZER Analyst and Snapshot reports.

Learn more about Zacks Equity Research reports

See more Zacks Equity Research reports

   

Fiscal Year End for Omnicell, Inc falls in the month of December.

All items in Millions except Per Share data.

12/31/2023 12/31/2022 12/31/2021 12/31/2020 12/31/2019
Assets          
Cash & Equivalents 468 330 349 486 127
Receivables 252 299 241 190 218
Notes Receivable 0 0 0 0 0
Inventories 110 148 120 96 108
Other Current Assets 97 104 71 57 30
Total Current Assets 928 882 781 829 483
Net Property & Equipment 109 94 71 59 54
Investments & Advances 43 33 18 22 20
Other Non-Current Assets 0 0 0 0 0
Deferred Charges 33 22 16 15 14
Intangibles 947 977 1,017 668 461
Deposits & Other Assets 143 165 191 176 152
Total Assets 2,227 2,211 2,143 1,825 1,241
Liabilities & Shareholders Equity 12/31/2023 12/31/2022 12/31/2021 12/31/2020 12/31/2019
Notes Payable 0 0 0 0 0
Accounts Payable 45 63 72 40 46
Current Portion Long-Term Debt 0 0 488 0 0
Current Portion Capital Leases 0 0 0 0 0
Accrued Expenses 201 246 204 136 100
Income Taxes Payable 0 0 0 0 0
Other Current Liabilities 122 119 112 100 91
Total Current Liabilities 368 428 876 276 237
Mortgages 0 0 0 0 0
Deferred Taxes/Income 60 39 72 45 46
Convertible Debt 570 567 0 467 0
Long-Term Debt 0 0 0 0 50
Non-Current Capital Leases 0 0 0 0 0
Other Non-Current Liabilities 6 7 8 19 12
Minority Interest (Liabilities) 0 0 0 0 0
Total Liabilities 1,038 1,081 996 857 396
Shareholders Equity 12/31/2023 12/31/2022 12/31/2021 12/31/2020 12/31/2019
Preferred Stock 0 0 0 0 0
Common Stock (Par) 0 0 0 0 0
Capital Surplus 1,122 1,047 1,025 920 781
Retained Earnings 370 391 369 291 259
Other Equity -13 -17 -8 -6 -9
Treasury Stock 290 290 238 238 185
Total Shareholder's Equity 1,189 1,130 1,147 968 845
Total Liabilities & Shareholder's Equity 2,227 2,211 2,143 1,825 1,241
Total Common Equity 1,189 1,130 1,147 968 845
Shares Outstanding 45.40 44.20 43.90 42.30 41.90
Book Value Per Share 26.19 25.57 26.12 22.87 20.17

Fiscal Year End for Omnicell, Inc falls in the month of December.

All items in Millions except Per Share data.

3/31/2024 12/31/2023 9/30/2023 6/30/2023 3/31/2023
Assets          
Cash & Equivalents -99,999 468 447 399 340
Receivables NA 252 273 274 322
Notes Receivable NA 0 0 0 0
Inventories NA 110 116 131 141
Other Current Assets NA 97 78 77 131
Total Current Assets NA 928 914 881 935
Net Property & Equipment NA 109 107 103 98
Investments & Advances NA 43 42 35 33
Other Non-Current Assets NA 0 0 0 0
Deferred Charges NA 33 36 33 30
Intangibles NA 947 953 962 970
Deposits & Other Assets NA 143 145 152 157
Total Assets NA 2,227 2,222 2,194 2,251
Liabilities & Shareholders Equity 3/31/2024 12/31/2023 9/30/2023 6/30/2023 3/31/2023
Notes Payable NA 0 0 0 0
Accounts Payable NA 45 50 47 63
Current Portion Long-Term Debt NA 0 0 0 0
Current Portion Capital Leases NA 0 0 0 0
Accrued Expenses NA 201 194 198 247
Income Taxes Payable NA 0 0 0 0
Other Current Liabilities NA 122 125 125 143
Total Current Liabilities NA 368 369 370 454
Mortgages NA 0 0 0 0
Deferred Taxes/Income NA 60 57 50 44
Convertible Debt NA 570 569 568 567
Long-Term Debt NA 0 0 0 0
Non-Current Capital Leases NA 0 0 0 0
Other Non-Current Liabilities NA 6 6 6
Minority Interest (Liabilities) NA 0 0 0 0
Total Liabilities NA 1,038 1,034 1,030 1,108
Shareholders Equity 3/31/2024 12/31/2023 9/30/2023 6/30/2023 3/31/2023
Preferred Stock NA 0 0 0 0
Common Stock (Par) NA 0 0 0 0
Capital Surplus NA 1,122 1,110 1,089 1,073
Retained Earnings NA 370 385 379 376
Other Equity NA -13 -17 -14 -16
Treasury Stock NA 290 290 290 290
Total Shareholder's Equity NA 1,189 1,187 1,164 1,143
Total Liabilities & Shareholder's Equity NA 2,227 2,222 2,194 2,251
Total Common Equity 0 1,189 1,187 1,164 1,143
Shares Outstanding 45.90 45.40 45.40 45.20 45.00
Book Value Per Share 0.00 26.19 26.16 25.74 25.39